Genus, Meet Species: Court Weighs Novo Nordisk’s Semaglutide Patent
Novo Nordisk A/S took Dr Reddy's Laboratories to the Delhi High Court over its Semaglutide patent, seeking to block generic imports of the anti-diabetic drug. Would the court…
Dr. Reddy’s Laboratories
2 articles
Rebanta Healthcare gets hurt in fight over the mark “REBAHEAL”
The Delhi High Court has issued an interim order restraining Rebanta Healthcare from using the REBAHEAL mark following a trademark infringement suit by Dr. Reddy’s. The court found…